Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-09-19T00:15:57.670Z.
Calculation as of: 2026-09-19T00:15:57.670Z.
Quote observation: 2026-09-18T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9edfc78ac10ef3c00dfd6e8891c60c5ddca660cc4cfb74c64a12c551c30ed6c4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$5.10B
EBITDA Yield
6.17%
TTM Avg
6.32%
3Y Avg
5.15%
5Y Avg
4.73%
Market Cap
$5.59B
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $376.61M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $463.35M | 4.25% | 6.81% | 7.36% | 6.55% |
| PDS Biotechnology Corporation (PDSB)vs › | $45.05M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.14B | 7.22% | 4.01% | 2.00% | 2.00% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.91B | 21.44% | 14.19% | 6.13% | 6.93% |
| TransMedics Group, Inc. (TMDX)vs › | $2.99B | 3.49% | 2.93% | 2.15% | 2.15% |
| Doximity, Inc. (DOCS)vs › | $4.88B | 4.58% | 4.24% | 3.10% | 2.47% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 6.17% | 6.32% | 5.15% | 4.73% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.59B | N/A | N/A | N/A | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | N/A | 1.73% | 1.16% | 1.16% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute